APA (7th ed.) Citation

K, T., I, B., D, N., D, A., D, G., B, G., . . . PS, M. (2011). Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer discovery, 1(6), 524. https://doi.org/10.1158/2159-8290.CD-11-0124

Chicago Style (17th ed.) Citation

K, Tanaka, et al. "Oncogenic EGFR Signaling Activates an MTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance." Cancer Discovery 1, no. 6 (2011): 524. https://doi.org/10.1158/2159-8290.CD-11-0124.

MLA (9th ed.) Citation

K, Tanaka, et al. "Oncogenic EGFR Signaling Activates an MTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance." Cancer Discovery, vol. 1, no. 6, 2011, p. 524, https://doi.org/10.1158/2159-8290.CD-11-0124.